W. Joseph Herring

3.6k total citations
55 papers, 2.6k citations indexed

About

W. Joseph Herring is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Endocrine and Autonomic Systems. According to data from OpenAlex, W. Joseph Herring has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cognitive Neuroscience, 33 papers in Experimental and Cognitive Psychology and 17 papers in Endocrine and Autonomic Systems. Recurrent topics in W. Joseph Herring's work include Sleep and related disorders (33 papers), Sleep and Wakefulness Research (33 papers) and Circadian rhythm and melatonin (16 papers). W. Joseph Herring is often cited by papers focused on Sleep and related disorders (33 papers), Sleep and Wakefulness Research (33 papers) and Circadian rhythm and melatonin (16 papers). W. Joseph Herring collaborates with scholars based in United States, Germany and Canada. W. Joseph Herring's co-authors include Christopher Lines, Ellen Snyder, David Michelson, Thomas Roth, Jill Hutzelmann, Duane Snavely, Valina L. Dawson, Ted M. Dawson, Kerry Budd and Andrew D. Krystal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

W. Joseph Herring

53 papers receiving 2.5k citations

Peers

Countries citing papers authored by W. Joseph Herring

Since Specialization

Citations

This map shows the geographic impact of W. Joseph Herring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Joseph Herring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Joseph Herring more than expected).

Fields of papers citing papers by W. Joseph Herring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Joseph Herring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Joseph Herring. The network helps show where W. Joseph Herring may publish in the future.

Co-authorship network of co-authors of W. Joseph Herring

This figure shows the co-authorship network connecting the top 25 collaborators of W. Joseph Herring. A scholar is included among the top collaborators of W. Joseph Herring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Joseph Herring. W. Joseph Herring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sugammadex for Reversal of Neuromuscular Blockade in Neonates and Infants Less than 2 Years Old: Results from a Phase IV Randomized Clinical Trial 2025 ·Anesthesiology ·Edith Mensah‐Osman, Yuki Mukai, (unknown), Maria Matuszczak, Vera Saldien, Heather Leibensperger, (unknown), (unknown), Rebecca E. Wrishko, Alison Gee, W. Joseph Herring	1
2	Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study 2021 ·Pediatric Anesthesia ·Tiffini Voss, (unknown), (unknown), (unknown), Vera Saldien, Gregory B. Hammer, Rebecca E. Wrishko, W. Joseph Herring	11
3	Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's disease 2021 ·Journal of Sleep Research ·Vladimir Svetnik, Ting‐Chuan Wang, Paulette Ceesay, Ellen Snyder, (unknown), Donald L. Bliwise, Kerry Budd, Jill Hutzelmann, Joanne Stevens, Christopher Lines, David Michelson, W. Joseph Herring	14
4	Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial 2021 ·BMC Anesthesiology ·Jay Horrow, (unknown), Manfred Blobner, (unknown), (unknown), (unknown), W. Joseph Herring	14
5	A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants 2021 ·BMC Anesthesiology ·W. Joseph Herring, Yuki Mukai, Aobo Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Manfred Blobner	7
6	Use of the single‐item Patient Global Impression‐Severity scale as a self‐reported assessment of insomnia severity 2020 ·Journal of Sleep Research ·Ellen Snyder, Peining Tao, Vladimir Svetnik, Christopher Lines, W. Joseph Herring	7
7	How well can a large number of polysomnography sleep measures predict subjective sleep quality in insomnia patients? 2019 ·Sleep Medicine ·Vladimir Svetnik, Ellen Snyder, Peining Tao, Thomas Roth, Christopher Lines, W. Joseph Herring	11
8	Clinical Polysomnography Trial of Suvorexant for Treating Insomnia in Alzheimer’s Disease (P3.6-022) 2019 ·Neurology ·W. Joseph Herring, Paulette Ceesay, Ellen Snyder, Donald L. Bliwise, Kerry Budd, Jill Hutzelmann, Joanne Stevens, David Michelson	1
9	Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications 2018 ·Journal of Sleep Research ·W. Joseph Herring, Thomas Roth, Andrew D. Krystal, David Michelson	35
10	Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data 2017 ·Psychopharmacology ·W. Joseph Herring, Kathryn M. Connor, Ellen Snyder, Duane Snavely, Ying Zhang, Jill Hutzelmann, Deborah Matzura‐Wolfe, Ruth M. Benca, Andrew D. Krystal, James K. Walsh, Christopher Lines, Thomas Roth, David Michelson	16
11	Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies 2017 ·Journal of Clinical Anesthesia ·W. Joseph Herring, Tiffany Woo, Christopher Assaid, Robert Lupinacci, Hendrikus J. M. Lemmens, Manfred Blobner, Karin S. Khuenl-Brady	33
12	Clinical Trial Design for Assessment of the Orexin Receptor Antagonist Suvorexant in the Treatment of Insomnia in Patients with Alzheimer’s Disease (P3.066) 2017 ·Neurology ·W. Joseph Herring, Ellen Snyder, Donald L. Bliwise, Sonia Ancoli‐Israel, Kerry Budd, Jill Hutzelmann, Tien Dam, David Michelson	1
13	A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia 2016 ·The International Journal of Neuropsychopharmacology ·Kathryn M. Connor, Erin Mahoney, (unknown), Jill Hutzelmann, Xin Zhao, Nan Jia, Ellen Snyder, Duane Snavely, David Michelson, Thomas Roth, W. Joseph Herring	36
14	Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man 2016 ·Scientific Reports ·Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, Joanne Stevens, Vladimir Svetnik, Ka Lai Yee, Xiaodong Li, Anthony J. Roecker, Steven V. Fox, Pamela L. Tannenbaum, Susan L. Garson, Inge De Lepeleire, Nicole Calder, Laura Rosen, Arie Struyk, Paul J. Coleman, W. Joseph Herring, John J. Renger, Christopher J. Winrow	67
15	Orexin receptor antagonism for treatment of insomnia 2012 ·Neurology ·W. Joseph Herring, Ellen Snyder, Kerry Budd, Jill Hutzelmann, Duane Snavely, Kenneth Liu, Christopher Lines, Thomas Roth, David Michelson	245
16	Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder 2012 ·The Journal of Clinical Psychiatry ·W. Joseph Herring, Timothy E. Wilens, Lenard A. Adler, Christine Baranak, Kenneth Liu, Duane Snavely, Christopher R. Lines, David Michelson	25
17	A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder 2012 ·Journal of Clinical Psychopharmacology ·Lobna Ibrahim, Nancy Diazgranados, (unknown), Nancy E. Brutsché, David A. Luckenbaugh, W. Joseph Herring, William Z. Potter, Carlos A. Zarate	175
18	Use of Terminal and Nucleus Birth Weights to Improve Commercial Pig Performance 2010 ·Proceedings of the World Congress on Genetics Applied to Livestock Production ·W. Joseph Herring, Jens Holl, (unknown), I. Misztal, (unknown), Jenna Fix, (unknown)	2
19	Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity 2003 ·Journal of Biological Chemistry ·Frederick C. Nucifora, Lisa Ellerby, Cheryl L. Wellington, (unknown), W. Joseph Herring, Akira Sawa, Michael R. Hayden, Valina L. Dawson, Ted M. Dawson, Christopher A. Ross	68
20	Nuclear Targeting of Mutant Huntingtin Increases Toxicity 1999 ·Molecular and Cellular Neuroscience ·Matthew F. Peters, Frederick C. Nucifora, (unknown), (unknown), Jillian K. Cooper, W. Joseph Herring, Valina L. Dawson, Ted M. Dawson, Christopher A. Ross	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact